GlassScriptPhysician profile
Jason E Fond
NPI 1003913807
$73,165.81
in general payments reported to CMS, 2019-2025
28 companies · $8,757 in 2025
The $8,757 reported for 2025 was more than what 86% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $10K · 2021: $5,979 · 2022: $12K · 2023: $16K · 2024: $2,820 · 2025: $8,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $7,592 · Travel and Lodging: $3,432 · Education: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,700.00 |
| Food and Beverage | $7,591.82 |
| Travel and Lodging | $3,431.92 |
| Education | $259.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $18,437.31 | 2022-2023 | Revomotion, Integrity Implant, Ovomotion |
| Medical Device Business Services, INC. | $14,710.09 | 2019-2022 | |
| Smith+Nephew, INC. | $13,788.15 | 2019-2025 | Acufex Meniscal Root Repair, Healicoil, Novostitch |
| Synthes USA Products LLC | $7,302.11 | 2020 | |
| Arthrex, INC. | $4,867.32 | 2019-2025 | |
| Depuy Synthes Sales INC. | $3,669.48 | 2019-2025 | Vapr, Chia Percpasser, Fms |
| Zimmer Biomet Holdings, INC. | $2,876.24 | 2019-2025 | Identity, Rosa, Comprehensive Shoulder System |
| Stryker Corporation | $2,622.41 | 2019-2025 | Mako, Gamma, Insignia |
| Seapearl East, INC | $2,238.17 | 2019-2025 | |
| Arthrosurface Incorporated | $1,297.70 | 2019 | |
| Globus Medical, INC. | $319.32 | 2022-2024 | Proximal Humerus Strut, Distal Humerus Fracture System |
| Horizon Therapeutics Plc | $279.80 | 2019-2022 | |
| Nevro Corp. | $157.35 | 2019 | |
| Sanofi-Aventis U.S. LLC | $109.62 | 2019-2020 | |
| Fidia Pharma USA INC. | $107.99 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $88.30 | 2019 | |
| Endo Pharmaceuticals INC. | $54.76 | 2019-2020 | |
| Assertio Therapeutics, INC. | $35.56 | 2020 | |
| Bioventus LLC | $32.18 | 2019 | |
| Pacira Therapeutics, INC. | $24.42 | 2020 | |
| Baxter Healthcare | $24.41 | 2019 | |
| Daiichi Sankyo INC. | $22.89 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.53 | 2020 | |
| Ethicon US, LLC | $19.89 | 2023 | Vicryl, Stratafix, Pds |
| Integra Lifesciences Corporation | $19.17 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.94 | 2019 | |
| Pfizer INC. | $14.33 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Fond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.